Beta Wealth Group’s CVS Health CVS Stock Holding History

Beta Wealth Group’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$419K	Buy	5,828 +203	+4%	+$15.6K	0.17%	91
2025 Q4	$446K	Sell	5,625 -1,498	-21%	-$118K	0.18%	85
2025 Q3	$537K	Sell	7,123 -31,192	-81%	-$2.14M	0.21%	80
2025 Q2	$2.64M	Buy	38,315 +487	+1%	+$31.9K	0.97%	31
2025 Q1	$2.56M	Buy	37,828 +30,407	+410%	+$1.82M	0.92%	31
2024 Q4	$333K	Sell	7,421 -39,542	-84%	-$2.22M	0.15%	90
2024 Q3	$2.95M	Buy	46,963 +1,353	+3%	+$78.9K	1.33%	25
2024 Q2	$2.69M	Buy	45,610 +39,187	+610%	+$2.45M	1.28%	27
2024 Q1	$512K	Sell	6,423 -583	-8%	-$44.5K	0.25%	64
2023 Q4	$553K	Buy	7,006 +4	+0.1%	+$285	0.29%	54
2023 Q3	$489K	Buy	7,002 +202	+3%	+$14.3K	0.29%	61
2023 Q2	$470K	Buy	6,800 +1,900	+39%	+$135K	0.27%	64
2023 Q1	$364K	Buy	4,900 +400	+9%	+$33.5K	0.21%	74
2022 Q4	$419K	Buy	4,500 +300	+7%	+$28.9K	0.28%	61
2022 Q3	$400K	Buy	4,200 +200	+5%	+$19.8K	0.29%	51
2022 Q2	$371K	Buy	4,000 +300	+8%	+$29.3K	0.25%	55
2022 Q1	$374K	Buy	+3,700	New	+$389K	0.25%	53

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Beta Wealth Group's CVS Position: Q1 2026 in Review

Beta Wealth Group increased its CVS Health (CVS) stake by 3.6% in Q1 2026, buying an estimated $15.6K and bringing the position to 5,828 shares worth $419K. The position accounts for 0.17% of the portfolio, ranked #91.

Beta Wealth Group first reported a position in CVS in Q1 2022 and has held it in 17 quarters since. The position peaked at $2.95M in Q3 2024. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Beta Wealth Group held 5,828 shares of CVS Health worth $419K as of Q1 2026.
Beta Wealth Group bought 203 CVS Health shares in Q1 2026, an estimated $15.6K.
CVS Health made up 0.17% of Beta Wealth Group's portfolio in Q1 2026, its #91 holding.
Beta Wealth Group first reported a position in CVS Health in Q1 2022 and has held it in 17 quarters since.
Beta Wealth Group's CVS Health position peaked at $2.95M in Q3 2024.
1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Beta Wealth Group's 13F filing for Q1 2026, filed 7 May 2026.